Downregulation of BUBR1 Regulates the Proliferation and Cell Cycle of Breast Cancer Cells and Increases the Sensitivity of Cells to Cisplatin

Investigators showed that BUBR1 loss inhibited the phosphorylation of TAK1/JNK. In vitro and in vivo studies indicated the knockdown of BUBR1 rendered the breast cancer cells more sensitive to cisplatin.